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The Absence of a Microbiota Enhances TSLP
Expression in Mice with Defective Skin Barrier but
Does Not Affect the Severity of their Allergic
Inflammation
Laura J. Yockey1,4, Shadmehr Demehri1, Mustafa Turkoz1, Ahu Turkoz1, Philip P. Ahern2, Omar Jassim1,
Sindhu Manivasagam1, John F. Kearney3, Jeffrey I. Gordon2 and Raphael Kopan1
Evidence is accumulating to suggest that our indigenous microbial communities (microbiota) may have a role in
modulating allergic and immune disorders of the skin. To examine the link between the microbiota and atopic
dermatitis (AD), we examined a mouse model of defective cutaneous barrier function with an AD-like disease
due to loss of Notch signaling. Comparisons of conventionally raised and germ-free (GF) mice revealed a similar
degree of allergic skin inflammation, systemic atopy, and airway hypersensitivity. GF mutant animals expressed
significantly higher levels of thymic stromal lymphopoietin, a major proinflammatory cytokine released by skin
with defective barrier function, resulting in a more severe B-lymphoproliferative disorder that persisted into
adulthood. These findings suggest a role for the microbiota in ameliorating stress signals released by
keratinocytes in response to perturbation in cutaneous barrier function.
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INTRODUCTION
Atopic dermatitis (AD) is a common allergic disease that
affects about 10% of children in the United States and
generally resolves by puberty (Spergel, 2010). However, up
to 70% of individuals with a history of AD go on to develop
asthma and other atopic disorders later in life, a phenomenon
called the ‘‘atopic march’’ (Spergel and Paller, 2003; Spergel,
2010). AD flare-ups are known to be associated with
overgrowth of bacterial species, including Staphylococcus
aureus, in barrier-defective lesional skin (Boguniewicz and
Leung, 2011; Kong et al., 2012). Paradoxically, increased AD
prevalence correlates with improvements in human hygiene in
the last century. One explanation for this correlation is that
improved hygiene and increased use of antibiotics have led to
decreases in host exposure to microorganisms (Kalliomaki
et al., 2001; Umetsu et al., 2002; Yazdanbakhsh et al., 2002;
Romagnani, 2004; Macia et al., 2012), which may in turn alter
immune responses leading to an increase in atopy.
In this study, we used a mouse model of AD generated by
removing the floxed alleles of RBPj, the DNA-binding partner
of Notch, in the skin via expression of a Msx2-Cre transgene
(Demehri et al., 2008; Dumortier et al., 2010). RBPj and
Notch signaling are essential for coordinating terminal
differentiation of epidermal keratinocytes and for formation
of a competent barrier (Blanpain et al., 2006). The Msx2-Cre
transgene (Demehri et al., 2008; Dumortier et al., 2010)
deletes RBPjflox in a mosaic (calico) pattern along the back
and stomach of the mouse, allowing juxtaposed patches of
RBPj-deficient and wild-type skin to be compared and
contrasted (Demehri et al., 2008). These mice exhibit many
of the hallmarks of AD including T helper (Th)2–mediated skin
inflammation, high serum IgE levels, and greater susceptibility
to asthma (Demehri et al., 2009; Dumortier et al., 2010).
In addition, these mice develop a marked, transient B-cell
expansion early in life and a myeloproliferative disorder in
adulthood (Demehri et al., 2008, 2009; ; Dumortier et al.,
2010).
Epidermal-derived thymic stromal lymphopoietin (TSLP), an
IL-7-like cytokine, is responsible for driving inflammation,
B-cell expansion, and allergen sensitization in these animals
(Demehri et al., 2009; Zhang et al., 2009; Han et al., 2012).
Moreover, TSLP is both necessary and sufficient to drive
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asthma in another mouse model, and it is upregulated in
several models displaying cutaneous barrier defects (Demehri
et al., 2008; Comeau and Ziegler, 2010; Ziegler and Artis,
2010).
Germ-free (GF) mice are widely accepted as being an
invaluable tool to characterize the impact of indigenous
microbial communities on host physiology. For example,
comparisons of GF mice and mice colonized with gut
microbiota harvested from conventionally raised (CONV-R)
mouse donors that have been subjected to deliberately
manipulated host and environmental factors, or from human
donors representing a variety of physiological or disease states,
have provided important insights about the causal relation-
ship between the microbiota and obesity (Turnbaugh et al.,
2006; Turnbaugh et al., 2009; Liou et al., 2013), immune
development (Ivanov et al., 2009), metabolic syndrome
(Vijay-Kumar et al., 2010), cardiovascular disease (Wang
et al., 2011), and severe acute malnutrition (Smith et al.,
2013). To investigate the role that indigenous microbes
have in modulating local as well as systemic inflammation,
we generated GF Msx2-Cre/þ ;RBP-jflox/flox and wild-type
littermate controls. GF status did not affect allergic skin
inflammation and asthma susceptibility in mutant or wild-
type mice contrary to the prediction of the hygiene hypothesis.
However, GF mutant mice produced significantly higher
levels of epidermal TSLP than their microbe-laden,
CONV-R counterparts, leading to a persistent expansion of
immature B cells. These results suggest a role for indige-
nous microbial communities in controlling TSLP levels
and helping mitigate some deleterious effects such as
B-lymphoproliferative disorder (B-LPD). They also highlight
the role of the microbiota in modulating cytokine production
by keratinocytes.
RESULTS
Morphogenesis and maintenance of the epidermis and hair
follicle in GF mice is unaltered
To assess the contribution of indigenous microbial commu-
nities to the phenotypes documented in our animals, we
re-derived Msx2-Cre/þ ;RBP-jflox/flox and wild-type littermate
control embryos into pseudopregnant sterile dams using an
embryo-transfer technique described in an earlier publication
(Faith et al, 2010). The GF status of the resulting mice was
confirmed by aerobic and anaerobic culture as well as by PCR
assays targeting conserved regions of the bacterial 16S rDNA
gene. Skin morphology and histology in wild-type GF and
CONV-R animals were indistinguishable (Figure 1a and c).
At postnatal day 9 (P9), Msx2-Cre/þ ;RBP-jflox/flox (RBPjCKO)
mutant skin had a thickened epidermis, a highly cellular
dermis and hair-follicle-derived epidermal cysts (Figure 1a).
These changes became more pronounced at P30 (Figure 1c)
and occurred independently of the presence or absence of
the microbiota. Immunocytochemical staining for filaggrin,
involucrin, and keratin-14 revealed that GF and CONV-R
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Figure 1. Epidermal and hair follicle structure are unaffected in germ-free (GF) mice compared with their conventionally raised (CONV-R) counterparts.
Hematoxylin and eosin (H&E) staining at (a) P9 and (c) P30 shows skin morphology and inflammation levels in GF and CONV-R RBPjCKO and wild-type mice.
Bar, 50mm. Immunocytochemical staining for keratin-14 (K14), involucrin (INV), and filaggrin (FLG) at (b) P9 and (d) P30 shows skin architecture in GF and
CONV-R wild-type and RBPjCKO animals. Both GF and CONV-R RBPjCKO animals exhibit similar barrier defects. Bar, 10mm.
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wild-type mice expressed these differentiation markers in the
granular, spinous, and basal epidermis, respectively (Figure 1b
and d). Conversely, RBPjCKO mice showed expansion of
keratin-14 into suprabasal cells at P9 (Figure 1b). At P30,
filaggrin and involucrin expression overlapped, an indication
of abnormal differentiation (Figure 1d). Trans-epidermal water
loss measurements detected a barrier defect of similar magni-
tude in P9 GF and CONV-R RBPjCKO mice (Supplementary
Figure S1 online). Collectively, these observations indicate
that morphological and functional characteristics of the skin
and the dysfunction caused by the absence of Notch signaling
are not modulated by the microbiota. This allowed us to ask
whether the microbiota has a role in skin inflammation and
atopy in the RBPjCKO model.
Skin inflammation and AD-like disease persist in GF RBPjCKO
mice
To better understand the role that indigenous microbial
communities have in skin inflammation and the systemic
diseases associated with cytokine production by the skin
with a chronic barrier defect, we analyzed RBPjCKO mice
at 10–13 weeks, the age at which the AD-like phenotype
develops (Demehri et al., 2009; Dumortier et al., 2010). GF
RBPjCKO mice were morphologically and histologically
indistinguishable from their CONV-R RBPjCKO counterparts
(Figure 2a), with all mice displaying the same macroscopic
signature of AD, including excoriation and scaling. Histologi-
cal analysis of hematoxylin and eosin–stained sections
revealed similar levels of hyperkeratosis, parakeratosis, and
acanthosis. Staining for CD45 (a pan hematopoietic cell
marker) and toluidine blue staining revealed similar levels of
skin inflammation and mast cell infiltration, respectively, in
both GF and CONV-R animals (Figure 2a and b). Tumor
resistance and loss of mutant keratinocytes are TSLP and
T cell–dependent consequences of the severe inflammatory
response that develops in RBPjCKO mice over a period of
75–200 days (Demehri et al., 2012; Di Piazza et al., 2012).
The absence of a microbiota did not affect this inflammatory,
Th2-mediated response.
Finally, systemic atopy, as measured by serum IgE levels,
was also not significantly different between the GF and
CONV-R RBPjCKO mice (Figure 2c); effector/memory
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Figure 2. Skin inflammation and atopic dermatitis (AD)–like disease persist
in germ-free (GF) RBPjCKO animals. (a) Conventionally raised (CONV-R)
and GF P80 mice. Scale bar, 1 cm. Hematoxylin and eosin (H&E), CD45
immunohistochemistry, and toluidine blue staining reveal skin inflammation
and mast cell infiltration in both CONV-R and GF wild-type (Wt) and
RBPjCKO (Mut) mice. Bar, 50mm. (b) Quantification of mast cells viewed in
three randomly selected microscopic fields at  200 (CONV-R Wt, n¼ 4;
CONV-R Mut, n¼ 15; GF Wt, n¼ 4; GF Mut, n¼15). (c) Serum IgE levels in
P80 Wt mice (CONV-R, n¼ 10; GF, n¼ 6) and RBPjCKO animals (CONV-R,
n¼ 23; GF, n¼23). (d) Flow cytometry gated on CD4þ T cells in the spleen
to detect effector (CD44hi CD62Llo) and naive (CD44lo CD62Lhi) cells in
RBPjCKO (CONV-R, n¼ 9; GF, n¼9) and Wt mice (CONV-R, n¼ 4; GF,
n¼ 4). A compilation of results from four independent experiments is shown.
(e) Flow cytometry gated on CD4þ T cells detects regulatory T cells (Treg,
Foxp3þ ) in RPBjCKO (GF and CONV-R, n¼ 6) and Wt mice (CONV-R and
GF, n¼ 3). A compilation of three independent experiments is shown. Asterisks
mark statistical significance; *Po0.05, **Po0.01, ***Po0.001 (unpaired
Student’s t-test).
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CD4þ T cells (CD44hiCD62Llo) were elevated to similar levels
in RBPjCKO mice in the spleen, skin-draining lymph nodes,
and mesenteric lymph nodes (Figure 2d and Supplementary
Figure S2 online). RBPjCKO animals had higher percentages
of FoxP3þ Treg cells among CD4þ T cells compared with
their wild-type littermates in the mesenteric and skin-draining
lymph nodes, as well as in the spleen (Figure 2e and
Supplementary Figure S2 online).
GF RBPjCKO mice have elevated TSLP levels but similar asthma
susceptibility
TSLP produced by the perturbed epidermis is a significant
driver of skin inflammation and many of the systemic effects in
this mouse model (Demehri et al., 2008, 2009, 2012). Given
the similar degree of disruption of epidermal differentiation
and cutaneous barrier function (Figures 1 and 2, and
Supplementary Figure S1 online), we were surprised to find
2-fold higher epidermal Tslp mRNA levels in the GF RBPjCKO
mice compared with CONV-R controls at P9 (Po0.05; n¼ 6–
10 mice/group; Figure 3a). Elevated Tslp mRNA levels in the
skin were associated with elevated serum TSLP levels at P9
and P30 (Figure 3b).
To determine whether the microbiota ameliorated the
severity of asthma in CONV-R mice, we subjected CONV-R
and GF mice to ovalbumin (OVA) sensitization and intranasal
challenge. Wild-type GF and CONV-R littermates displayed
similar mild responses to OVA challenge (Figure 3c). Simi-
larly, no significant differences in the severity of the asthmatic
response were detected between GF and CONV-R-RBPjCKO
animals, as judged by lung histology and total counts of
leukocytes in lung washings obtained by bronchoalveolar
lavage (Figure 3d, e). These data suggest that although the
microbiota might well regulate skin and serum levels of TSLP
in the absence of Notch signaling in the skin, the microbiota
does not modulate AD and asthma in this model.
GF RBPjCKO mice have elevated white blood cell counts and
persistent B-cell expansion
Epidermal-derived TSLP directly drives B-LPD in newborns.
B-LPD severity mirrors TSLP levels early in life but is resolved
after P30 despite persistently high TSLP levels (Demehri et al.,
2008). Myeloproliferative disorder (MPD) replaces B-LPD,
persisting into adulthood (Demehri et al., 2009; Dumortier
et al., 2010). Surprisingly, white blood cell (WBC) counts did
not normalize in young (P30-P45) GF RBPjCKO animals
(Figure 4a). At P80, WBC counts in GF RBPjCKO mice
remained significantly higher than in CONV-R animals,
splenomegaly was more severe (Figure 4a–c), B-cell numbers
were elevated (CD45þB220þ ; Figure 4d), and T-cell numbers
were unchanged (CD45þCD3þ ; Figure 4d) in the blood. As
previously reported, MPD in RBPjCKO animals coincided
with an increase in granulocyte colony-stimulating factor (G-
CSF). Although G-CSF levels were significantly lower in GF
RBPjCKO mice (Figure 4f), MPD (CD45þLy6Gþ ) persisted to
the same extent as it did in CONV-R RBPjCKO animals
(Figure 4d).
The hematocrit in both the GF and CONV-R RBPjCKO mice
was significantly lower than in their wild-type littermates
(Figure 4h). We hypothesized that epidermal-derived TSLP
may drive a B-cell-mediated autoimmune hemolytic anemia
(AIHA), which could cause low hematocrit (Iseki et al., 2012).
To test whether AIHA occurs in our mice, we measured the
levels of lactate dehyrogenase (LDH) and haptoglobin. In
AIHA, release of LDH from lysed red blood cells elevates its
level in serum, and because haptoglobin binds to hemoglobin
released from lysed red blood cells, its level plummets
(Tabbara, 1992). We detected no significant difference in
LDH levels between wild-type and RBPjCKO (Figure 4i,
Supplementary Figure S3A online), and serum haptoglobin
levels were significantly higher in both GF and CONV-R
RBPjCKO compared with wild-type mice (Figure 4j,
Supplementary Figure S3B online). We concluded that it is
unlikely that the anemia is due to AIHA. An alternative
explanation for the low hematocrit is that an expanded B-cell
and granulocytic compartment may cause a reactive contrac-
tion in other cell types without autoimmunity.
Analysis of P80 GF RBPjCKO mice identified both mature
(B220þ CD23þ CD93–; Supplementary Figure S2 online) and
immature (IgD– IgMþ ) B cells (Figure 4e). High levels of TSLP
in newborn GF RBPjCKO animals could affect neonatal B1
cell production dynamics or the activities of skin B1 cells in
adults (Vosshenrich et al., 2004; Geherin et al., 2012).
Accordingly, we detected a significantly elevated level of
resting anti-phosphorylcholine IgM, most of which is made by
B1 cells, in the sera of GF RBPjCKO mice (Figure 4g). This is
not solely a result of losing microbial antigens, as GF wild-
type mice have significantly lower levels of anti-phosphor-
ylcholine IgM than their CONV-R counterparts (Figure 4g).
Collectively, these data establish that the microbiota has
effects on B cells, but not T cells, in mice with chronic
cutaneous barrier defects.
DISCUSSION
The role of indigenous microbial communities in skin devel-
opment and function is only beginning to be explored (Lai
et al., 2009; Gallo and Nakatsuji, 2011; Grice and Segre,
2011; Naik et al., 2012). In this study, mice deficient in Notch
signaling in their skin that develop severe, chronic skin
inflammation and systemic atopy were re-derived as germ
free. Morphologically and histologically, skin pathology was
unaffected by the presence of a microbiota, and lack of a
microbiota did not modulate skin inflammation in these
animals. Surprisingly, despite these similarities, we observed
an increase in the production of TSLP by the skin and the
amount of TSLP in the serum of GF animals. These results
indicate that the microbiota has a role in suppressing TSLP
production in the barrier-defective skin.
TSLP is emerging as an essential cytokine in the develop-
ment of allergic responses (Yoo et al., 2005; Zhou et al., 2005;
Demehri et al., 2009; Zhang et al., 2009; Han et al., 2012;
Jiang et al., 2012). Local TSLP expression in the skin is
sufficient for the progression from AD to asthma (Han et al.,
2012). Consistent with the finding that TSLP is upregulated in
utero (Demehri et al., 2008), microbial products are not
necessary to induce TSLP expression in barrier-defective skin
but may instead limit its expression level or duration.
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In contrast to the transient B-LPD that is apparent in
neonatal CONV-R RBPjCKO mice and transitions to MPD in
adulthood, both B-LPD and MPD persist to adulthood in GF
animals (Demehri et al., 2008). Previously, we proposed
that fetal B cells are responsive to TSLP but marrow-derived
B cells are not (Demehri et al., 2008). The present study
demonstrates that marrow-derived B cells continue to be
responsive to TSLP in GF mice. It is possible that in GF
mice, B-cell maturation is delayed or altered in the presence
of TSLP, establishing a persistent B-LPD and expansion of
B1 cells. One mechanistic explanation may relate to the
lower G-CSF levels that we document in GF RBPjCKO
animals; G-CSF has been shown to suppress B cells in the
bone marrow (Dumortier et al., 2010; Winkler et al., 2012)
and could thus contribute to resolving B-LPD. These
observations also indicate that the link between TSLP and
G-CSF (Dumortier et al., 2010) does not require the
presence of a microbiota.
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Despite an increase in TSLP and WBC counts, we see no
evidence for a more severe allergic disease in GF RBPjCKO
animals. These findings do not support the hypothesis that
complete lack of a microbiota will create a runaway Th2-
skewed immune response in this model, but understanding the
generality of this observation will depend on the results of
similar experiments with other AD models. While our findings
clearly demonstrate that the microbiota modulates expression
of at least one proinflammatory cytokine in barrier-defective
skin, a task ahead is to identify which microbial species or
species consortia from which body habitat-associated com-
munities mediate these observed effects and through which
signaling pathways. Colonization of the GF mice we describe
in this report with components of the skin and/or gut
microbiota should provide a path ahead for addressing these
questions.
MATERIALS AND METHODS
Mice
All experiments involving mice were conducted using protocols
approved by the Animal Studies Committee of Washington Univer-
sity. Msx2-Cre/þ ;RBP-jflox/flox (RBPjCKO) mice were generated as
previously described (Pan et al., 2004). GF mice were derived by
embryo extraction, sterilization, and transfer into a pseudopregnant
sterile dam (Faith et al., 2010) and maintained in flexible film
gnotobiotic isolators under a strict 12-h light cycle on a standard
plant polysaccharide–rich low-fat chow diet fed ad libitum (B&K
Universal; England, UK). Maintenance of GF status in the colony was
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dehyrogenase (LDH) levels (Wt CONV-R and GF, n¼ 6; RBPjCKO CONV-R and GF, n¼ 12). (j) Serum haptoglobin levels (Wt CONV-R and GF, n¼ 6; RBPjCKO
CONV-R and GF, n¼ 12). *Po0.05, **Po0.01, ***Po0.001 (unpaired Student’s t-test).
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confirmed using culture-independent methods (i.e., negative PCR
assays of fecal DNA using universal primers directed against bacterial
16S rRNA genes), or culture-based approaches (culturing feces in
brain heart infusion broth, nutrient broth, or Sabouraud dextrose broth
under anaerobic conditions). We analyzed age- and sex- matched GF
wild-type littermates and their CONV-R siblings (i.e., mice derived
from the same founders but reared in a mouse barrier facility in a
specified pathogen-free state, and acquiring microbes from their
environment beginning at birth).
OVA treatment
Airway challenge was performed on GF and CONV-R mice as
outlined previously (Zhou et al., 2005). Six- to 8-week-old female
mice were sensitized by intraperitoneal injection of 250ml of a
solution containing 50mg OVA (Sigma A5503; St Louis, MO)
dissolved in phosphate-buffered saline and 1.3 mg aluminum
hydroxide gel (Sigma) on experimental days 1 (d1) and d14. Mice
were challenged intranasally with 150mg of OVA dissolved in 40ml of
phosphate-buffered saline on d21, d22, and d23. Controls were given
the same regimen without the addition of OVA antigen. Mice were
killed on d24.
Histology, immunohistochemistry, and immunofluorescence
After killing, lungs were inflated with 4% paraformaldehyde at 25 cm
water pressure. Dorsal skin and lung tissues were fixed in 4%
paraformaldehyde overnight, dehydrated in ethanol and embedded
in paraffin. Five-mm thick sections were used for all analyses. To
assess inflammation and skin morphology, sections were stained with
hematoxylin and eosin or toluidine blue. Mast cell infiltration in the
skin was quantified by counting the average number of toluidine blue
positive cells in three randomly selected microscopic fields at 200x
magnification. Paraffin embedded sections were rehydrated and
stained with biotinlylated anti-keratin 14 (clone LL002, Neomarkers),
chick anti-filaggrin, and rabbit anti-involucrin, and antigen-antibody
complexes were visualized with Cy5-conjugated streptavidin, Cy3-
conjugated anti-rabbit Ig, and Alexa488-conjugated anti-chicken Ig
(all from Jackson ImmunoResearch Laboratory). CD45 staining was
performed as previously described (Demehri et al., 2012).
Bronchoalveolar and WBC analyses
Bronchoalveolar fluid was collected by infusing 1 ml of phosphate-
buffered saline into the lung at killing using a Surflo catheter (Terumo
Medical; Somerset, NJ) (Demehri et al., 2009). Bronchoalveolar fluid
was spun down, the cell pellet was stained with Giemsa, and at least
100 cells were counted to determine the differential leukocyte cell
counts. Blood was diluted 1:1 with 10 mM EDTA in phosphate-
buffered saline, and total white blood cell count and hematocrit
were measured using a Hemavet 950 analyzer (Drew Scientific;
Waterbury, CT).
Serology
Serum IgE was determined using Mouse IgE ELISA (Immunology
Consultants Laboratory, Portland, OR). Serum TSLP and G-CSF levels
were measured using Mouse TSLP ELISA (Biolegend; San Diego, CA)
and Mouse G-CSF ELISA (R&D Systems; Minneapolis, MN), respec-
tively. Serum anti-phosphorylcholine IgM was measured by coating
96-well flat-bottom EIA/RIA plates (Costar; Tewksbury, MA) overnight
at 4 1C with 2mg ml 1 of PC-BSA and performing ELISA assays (Foote
and Kearney, 2009). To test for hemolytic anemia, serum LDH was
determined using LDH cytotoxicity assay (Cayman Chemical
Company; Ann Arbor, MI), and serum haptoglobin was measured
using Mouse Haptoglobin Elisa Test Kit (Life Diagnostics; West
Chester, PA).
Flow cytometry
This method was applied to single-cell suspensions prepared from
spleen, skin-draining lymph nodes, or mesenteric lymph nodes. Cells
were surface stained with the reagents listed in Supplementary
Materials and Methods, fixed overnight at 4 1C using FoxP3 fixation/
permabilization buffer (eBioscience; San Diego, CA), and stained
intracellularly using FoxP3 Permeabilization buffer as per the
manufacturer’s instructions. Samples were acquired on a BD FACS
can or BD LSR II flow cytometer. Data were analyzed using FlowJo
software (TreeStar; Ashland, OR).
PCR and quantitative real-time reverse-transcriptase–PCR
To genotype mice, PCR was performed on DNA extracted from toes
(Demehri et al., 2009). For gene expression analysis, mice were
euthanized on P9, the skin was removed and placed on dry ice. The
epidermis was scraped off using a scalpel, homogenized, and RNA
was isolated using RNeasy Mini Kit (Qiagen; Germantown, MD).
cDNA was generated using Superscrpipt RT-II kit (Invitrogen; Grand
Island, NY). Quantitative real-time reverse-transcriptase–PCR was
performed for mouse Tslp and Hprt mRNA (control) as previously
described (Lee et al., 2007; Demehri et al., 2008).
Statistical analysis
An unpaired Student’s t-test was used to test statistical significance;
Po0.05 was considered significant. Mean values±SEM are presented
in all graphs.
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